Obstacles to improving outcomes in the treatment of uveal melanoma

被引：17
|
作者：
Tsai, Katy K. [1 ]
Bollin, Kathryn B. [2 ]
Patel, Sapna P. [3 ]
机构：
[1] Univ Calif San Francisco, Cutaneous Oncol, Hellen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[2] Scripps Clin, Div Hematol & Oncol, La Jolla, CA 92037 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源：
CANCER | 2018年 / 124卷 / 13期
基金：
美国国家卫生研究院;
关键词：
barriers; challenges; outcomes; success; therapy; treatment; trials; uveal melanoma; INTRAARTERIAL HEPATIC FOTEMUSTINE; DEPENDENT PROBE AMPLIFICATION; GENE-EXPRESSION PROFILE; LIVER METASTASES; CHOROIDAL MELANOMA; DOUBLE-BLIND; PROGNOSTIC IMPLICATIONS; UNTREATED MELANOMA; COMPLETE RESECTION; TUMOR DIAMETER;
D O I：
10.1002/cncr.31284
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The rate of advances in uveal melanoma has not kept pace with the rate of advances in cutaneous melanoma. Many patients lack access to or knowledge of specialty centers, and integrated multidisciplinary care between ophthalmology, radiation oncology, and medical oncology is far from the norm. This treatment isolation leads to limited communication about novel clinical trial opportunities. Clinical trials themselves are not widely available, and a lack of robust funding limits rapid and complete investigations. This review outlines the obstacles to success in uveal melanoma management and highlights strategies for overcoming these challenges. (C) 2018 American Cancer Society.
引用
收藏
页码：2693 / 2703
页数：11
相关论文
共 50 条
  • [1] Uveal Melanoma Metastatic to the Liver: Treatment Trends and Outcomes
    Xu, Lucy T.
    Funchain, Pauline F.
    Bena, James F.
    Li, Manshi
    Tarhini, Ahmad
    Berber, Eren
    Singh, Arun D.
    OCULAR ONCOLOGY AND PATHOLOGY, 2019, 5 (05) : 323 - 332
  • [2] Clinical features and treatment outcomes of progressive uveal melanoma
    Rancelyte, Milda
    Pamedys, Justinas
    Grigiene, Ruta
    Brasiuniene, Birute
    ARCHIVE OF CLINICAL CASES, 2023, 10 (02): : 102 - 106
  • [3] Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre
    Wong, Wendy
    Sundar, Gangadhara
    Chee, Caroline
    Zhao, Paul Songbo
    Rajagopalan, Rajesh
    Gopal, Lingam
    SINGAPORE MEDICAL JOURNAL, 2019, 60 (09) : 474 - 478
  • [4] Auditing outcomes after treatment of Scottish patients with uveal melanoma in Liverpool
    Wright, PK
    Damato, BE
    JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH, 1999, 44 (04): : 260 - 264
  • [5] Outcomes of quercetin treatment on the metastatic profile of a uveal melanoma cell line
    Sonnentag, Laurenz L.
    Kraus, Anna
    Ranjbar, Mandy
    Lueke, Julia
    Grisanti, Salvatore
    Tura, Aysegul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [6] FNAB of Uveal Melanoma : Outcomes and Complications
    Singh, Arun D.
    Mendez, Carlos A. Medina
    Singh, Nakul
    Aronow, Mary E.
    Aziz, Hassan A.
    Biscotti, Charles V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [7] TREATMENT OF POSTERIOR UVEAL MELANOMA
    MANSCHOT, WA
    OPHTHALMOLOGICA, 1986, 192 (02) : 121 - 121
  • [8] The treatment of metastatic uveal melanoma
    Pyrhönen, S
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S27 - S30
  • [9] Uveal Melanoma: Refusal of Treatment
    Bowen, Randy Christopher
    Hansell, Soto
    Raval, Vishal
    Davanzo, Jacquelyn M.
    Singh, Arun D.
    OCULAR ONCOLOGY AND PATHOLOGY, 2021, 7 (05) : 361 - 367
  • [10] Update on the Treatment of Uveal Melanoma
    Carvajal, Richard D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (10) : 768 - 770
12345